treatment of rheumatoid arthritis based on prsonalized medicine: a new approach in rheumatology

In the twenty-first century, there still needs more clarity on rheumatoid arthritis (ra). rheumatoid arthritis is a widespread but heterogeneous illness with a broad range in its history, clinical symptoms, and response to therapy. it is now known that prevention of joint destruction, functional impairment, and a poor disease prognosis depends on early, correct diagnosis and starting therapy with disease-modifying drugs (dmards), among which methotrexate (mtx) remains the gold standard in the treatment of ra. early rheumatoid arthritis diagnosis is crucial since it enables a speedier start to primary therapy. pharmacogenetic and pharmacogenomic research, which aid in identifying a patient’s genetic profile, may bring personalized treatment closer to reality. identifying disease-specific genes while the organism’s resistance to them is still intact should be made feasible by further study into ra.